US regulators on Monday authorized Pfizer and its partner BioNTech’s Covid-19 vaccine for use in children as young as 12, widening the country’s inoculation program even as vaccination rates have slowed significantly.
The vaccine has been available under an emergency use authorization (EUA) to people as young as 16 in the United States.
The vaccine makers said they had started the process for full approval for those ages last week.
The US Food and Drug Administration said it was amending the EUA to include the millions of children aged 12 to 15.
More details soon …
This content first appear on the guardian